View Item 

Show simple item record

Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data
dc.contributor.authorWilliams, Randi M.
dc.contributor.authorLi, Tengfei
dc.contributor.authorLuta, George
dc.contributor.authorWang, Min Qi
dc.contributor.authorAdams-Campbell, Lucile
dc.contributor.authorMeza, Rafael
dc.contributor.authorTammemägi, Martin C.
dc.contributor.authorTaylor, Kathryn L.
dc.date.accessioned2022-05-06T17:25:22Z
dc.date.available2023-06-06 13:25:21en
dc.date.available2022-05-06T17:25:22Z
dc.date.issued2022-05-01
dc.identifier.citationWilliams, Randi M.; Li, Tengfei; Luta, George; Wang, Min Qi; Adams-Campbell, Lucile ; Meza, Rafael; Tammemägi, Martin C. ; Taylor, Kathryn L. (2022). "Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data." Cancer (9): 1812-1819.
dc.identifier.issn0008-543X
dc.identifier.issn1097-0142
dc.identifier.urihttps://hdl.handle.net/2027.42/172243
dc.publisherWiley Periodicals, Inc.
dc.publisherCenters for Disease Control and Prevention
dc.subject.otherlung cancer screening
dc.subject.otherUS Preventive Services Task Force
dc.subject.otherrace disparities
dc.subject.otherBehavioral Risk Factor Surveillance System
dc.subject.otherlow dose computed tomography
dc.subject.otherPLCOm2012 risk prediction model
dc.titleLung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPublic Health
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/172243/1/cncr34098.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/172243/2/cncr34098_am.pdf
dc.identifier.doi10.1002/cncr.34098
dc.identifier.sourceCancer
dc.identifier.citedreferenceDarling GE, Tammemägi MC, Schmidt H, et al. Organized lung cancer screening pilot: informing a province-wide program in Ontario, Canada. Ann Thorac Surg. 2021; 111: 1805 - 1811. doi: 10.1016/j.athoracsur.2020.07.051
dc.identifier.citedreferencePasquinelli MM, Kovitz KL, Koshy M, et al. Outcomes from a minority-based lung cancer screening program vs the National Lung Screening Trial. JAMA Oncol. 2018; 4: 1291. doi: 10.1001/jamaoncol.2018.2823
dc.identifier.citedreferenceAnnangi S, Nutalapati S, Foreman MG, Pillai R, Flenaugh EL. Potential racial disparities using current lung cancer screening guidelines. J Racial Ethn Health Disparities. 2019; 6: 22 - 26. doi: 10.1007/s40615-018-0492-z
dc.identifier.citedreferenceCDCTobaccoFree. Burden of tobacco use in the U.S. Centers for Disease Control and Prevention. Published April 23, 2018. Accessed May 14, 2018. https://www.cdc.gov/tobacco/campaign/tips/resources/data/cigarette-smoking-in-united-states.html
dc.identifier.citedreferenceHan SS, Chow E, ten Haaf K, et al. Disparities of national lung cancer screening guidelines in the U.S. population. J Natl Cancer Inst. 2020; 112: 1136 - 1142. doi: 10.1093/jnci/djaa013
dc.identifier.citedreferenceCenters for Disease Control and Prevention. Racial/ethnic disparities and geographic differences in lung cancer incidence—38 states and the District of Columbia, 1998-2006. MMWR Morb Mortal Wkly Rep. 2010; 59: 1434 - 1438.
dc.identifier.citedreferencede Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020; 382: 503 - 513. doi: 10.1056/NEJMoa1911793
dc.identifier.citedreferenceLandy R, Young CD, Skarzynski M, et al. Using prediction-models to reduce persistent racial/ethnic disparities in draft 2020 USPSTF lung-cancer screening guidelines. J Natl Cancer Inst. 2021; 113: 1590 - 1594. doi: 10.1093/jnci/djaa211
dc.identifier.citedreferenceHenderson LM, Rivera MP, Basch E. Broadened eligibility for lung cancer screening: challenges and uncertainty for implementation and equity. JAMA. 2021; 325: 939 - 941. doi: 10.1001/jama.2020.26422
dc.identifier.citedreferenceRyan BM. Lung cancer health disparities. Carcinogenesis. 2018; 39: 741 - 751. doi: 10.1093/carcin/bgy047
dc.identifier.citedreferenceHaiman CA, Stram DO, Wilkens LR, et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med. 2006; 354: 333 - 342. doi: 10.1056/NEJMoa033250
dc.identifier.citedreferencePasquinelli MM, Tammemagi MC, Kovitz KL, et al. Risk prediction model versus United States Preventive Services Task Force lung cancer screening eligibility criteria: reducing race disparities. J Thorac Oncol. 2020; 15: 1738 - 1747. doi: 10.1016/j.jtho.2020.08.006
dc.identifier.citedreferenceTammemägi MC, Katki HA, Hocking WG, et al. Selection criteria for lung-cancer screening. N Engl J Med. 2013; 368: 728 - 736. doi: 10.1056/NEJMoa1211776
dc.identifier.citedreferenceFiscella K, Winters P, Farah S, Sanders M, Mohile SG. Do lung cancer eligibility criteria align with risk among Blacks and Hispanics? PLoS One. 2015; 10: e0143789. doi: 10.1371/journal.pone.0143789
dc.identifier.citedreferenceten Haaf K, Jeon J, Tammemägi MC, et al. Risk prediction models for selection of lung cancer screening candidates: a retrospective validation study. PLoS Med. 2017; 14: e1002277. doi: 10.1371/journal.pmed.1002277
dc.identifier.citedreferenceKatki HA, Kovalchik SA, Petito LC, et al. Implications of nine risk prediction models for selecting ever-smokers for computed tomography lung cancer screening. Ann Intern Med. 2018; 169: 10. doi: 10.7326/M17-2701
dc.identifier.citedreferenceNational Health Service England. Targeted screening for lung cancer with low radiation dose computed tomography. Accessed September 20, 2021. https://www.england.nhs.uk/publication/targeted-screening-for-lung-cancer/
dc.identifier.citedreferencePasquinelli MM, Tammemägi MC, Kovitz KL, et al. Addressing sex disparities in lung cancer screening eligibility: USPSTF vs PLCOm2012 criteria. Chest. 2021;Jul 9:S0012-3692(21)01316-70(0). doi: 10.1016/j.chest.2021.06.066
dc.identifier.citedreferenceTammemägi MC, Church TR, Hocking WG, et al. Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med. 2014; 11: e1001764. doi: 10.1371/journal.pmed.1001764
dc.identifier.citedreferenceMeza R, Jeon J, Toumazis I, et al. Evaluation of the benefits and harms of lung cancer screening with low-dose computed tomography: modeling study for the US Preventive Services Task Force. JAMA. 2021; 325: 988. doi: 10.1001/jama.2021.1077
dc.identifier.citedreferenceRubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med. 1991; 10: 585 - 598. doi: 10.1002/sim.4780100410
dc.identifier.citedreferenceReese TJ, Schlechter CR, Potter LN, et al. Evaluation of revised US Preventive Services Task Force lung cancer screening guideline among women and racial/ethnic minority populations. JAMA Netw Open. 2021; 4: e2033769. doi: 10.1001/jamanetworkopen.2020.33769
dc.identifier.citedreferenceHolford TR, Levy DT, Meza R. Comparison of smoking history patterns among African American and White cohorts in the United States born 1890 to 1990. Nicotine Tob Res. 2016; 18 ( suppl 1 ): S16 - S29. doi: 10.1093/ntr/ntv274
dc.identifier.citedreferenceCenters for Disease Control and Prevention. Hispanics/Latinos and tobacco use. Published December 17, 2018. Accessed September 20, 2021. https://www.cdc.gov/tobacco/disparities/hispanics-latinos/index.htm
dc.identifier.citedreferenceBenowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev. 1996; 18: 188 - 204. doi: 10.1093/oxfordjournals.epirev.a017925
dc.identifier.citedreferenceUS Census Bureau QuickFacts: United States. Accessed September 20, 2021. https://www.census.gov/quickfacts/fact/table/US/PST045219
dc.identifier.citedreferenceFedewa SA, Kazerooni EA, Studts JL, et al. State variation in low-dose computed tomography scanning for lung cancer screening in the United States. J Natl Cancer Inst. 2021; 113: 1044 - 1052. doi: 10.1093/jnci/djaa170
dc.identifier.citedreferenceFedewa SA, Bandi P, Smith RA, Silvestri GA, Jemal A. Lung cancer screening rates during the COVID-19 pandemic. Chest. 2021;July 21:S0012-3692(21)01364-7. doi: 10.1016/j.chest.2021.07.030
dc.identifier.citedreferenceMaki KG, Shete S, Volk RJ. Examining lung cancer screening utilization with public-use data: opportunities and challenges. Prev Med. 2021; 147: 106503. doi: 10.1016/j.ypmed.2021.106503
dc.identifier.citedreferenceAmerican Lung Association. Healthcare & lung disease initiatives. Accessed July 9, 2021. https://www.lung.org/policy-advocacy/healthcare-lung-disease/lung-cancer-policy/toolkit
dc.identifier.citedreferenceAmerican Cancer Society Cancer facts & figures for African Americans 2016-2018. Published online 2016. Accessed November 12, 2021. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-facts-and-figures-for-african-americans/cancer-facts-and-figures-for-african-americans-2016-2018.pdf
dc.identifier.citedreferenceZahnd WE, Eberth JM. Lung cancer screening utilization: a Behavioral Risk Factor Surveillance System analysis. Am J Prev Med. 2019; 57: 250 - 255. doi: 10.1016/j.amepre.2019.03.015
dc.identifier.citedreferenceJemal A, Fedewa SA. Lung cancer screening with low-dose computed tomography in the United States—2010 to 2015. JAMA Oncol. 2017; 3: 1278 - 1281. doi: 10.1001/jamaoncol.2016.6416
dc.identifier.citedreferenceAberle DR. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365: 395 - 409. doi: 10.1056/NEJMoa1102873
dc.identifier.citedreferenceMoyer VA. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014; 160: 330 - 338. doi: 10.7326/M13-2771
dc.identifier.citedreferenceAdvani S, Zhang D, Tammemagi M, et al. Comorbidity profiles and lung cancer screening among older adults: U.S. Behavioral Risk Factor Surveillance System 2017 to 2019. Ann Am Thorac Soc. 2021; 18: 1886 - 1893. doi: 10.1513/AnnalsATS.202010-1276OC
dc.identifier.citedreferenceKee D, Wisnivesky J, Kale MS. Lung cancer screening uptake: analysis of BRFSS 2018. J Gen Intern Med. 2021; 36: 2897 - 2899. doi: 10.1007/s11606-020-06236-9
dc.identifier.citedreferenceNarayan AK, Gupta Y, Little BP, Shepard JO, Flores EJ. Lung cancer screening eligibility and use with low-dose computed tomography: results from the 2018 Behavioral Risk Factor Surveillance System cross-sectional survey. Cancer. 2021; 127: 748 - 756. doi: 10.1002/cncr.33322
dc.identifier.citedreferenceRichards TB. Screening for lung cancer—10 states, 2017. MMWR Morb Mortal Wkly Rep. 2020; 69: 201 - 206. doi: 10.15585/mmwr.mm6908a1
dc.identifier.citedreferenceAldrich MC, Mercaldo SF, Sandler KL, Blot WJ, Grogan EL, Blume JD. Evaluation of USPSTF lung cancer screening guidelines among African American adult smokers. JAMA Oncol. 2019; 5: 1318. doi: 10.1001/jamaoncol.2019.1402
dc.identifier.citedreferencePinsky PF, Kramer BS. Lung cancer risk and demographic characteristics of current 20-29 pack-year smokers: implications for screening. J Natl Cancer Inst. 2015; 107: djv226. doi: 10.1093/jnci/djv226
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cncr34098.pdf
Size:
193.1KB
Format:
PDF
View/Open
Name:
cncr34098_am.pdf
Size:
252.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.